Consumers are living with problematic toxins.
Health remediation. MoldCo, a platform for those affected by mold-related illnesses, raised $3M in pre-seed funding.
Providing clinician assistance, lab tests, and treatment protocols, the startup hopes to bring light to an overlooked health issue.
Mold everywhere. ~50% of US households have some level of mold.
Long accepted as an unavoidable nuisance, there’s growing awareness of widespread chronic health issues like allergies, brain fog, and chronic inflammatory response syndrome (CIRS) — an underdiagnosed condition MoldCo hopes to bring into mainstream medicine.
Hazmat. Mold joins an expanding field of environmental toxins that consumers are eyeing critically, including pollution, microplastics, and forever chemicals.
Looking ahead: Frustration with lack of action from regulatory agencies is rising, and a growing population of wellness-motivated individuals are reassessing their day-to-day, desperate for a fresh start.
